Article Summary
总胆红素与白蛋白比值联合甲胎蛋白、异常凝血酶原 - II对原发性肝癌的诊断价值
Diagnostic value of total bilirubin to albumin ratio combine with alpha-fetoprotein and abnormal prothrombin induced by vitamin K absence-II for hepatocellular carcinoma
投稿时间:2025-03-15  修订日期:2025-03-15
DOI:
中文关键词: 原发性肝癌  总胆红素与白蛋白比值  甲胎蛋白  异常凝血酶原-II
英文关键词: Hepatocellular carcinoma  Total bilirubin to albumin ratio  Alpha-fetoprotein  Abnormal prothrombin induced by vitamin K absence-II
基金项目:赣州市指导性科技计划项目(GZ2021ZSF408)
作者单位邮编
李勇* 赣州市赣县区人民医院 341100
摘要点击次数: 5
全文下载次数: 0
中文摘要:
      目的:探讨总胆红素与白蛋白比值(B/A 比值)联合甲胎蛋白(AFP)、异常凝血酶原- II(PIVKA-II)对原发性肝癌(HCC)的诊断价值。方法:选取我院2023年1月-2024年12月收治的35例HCC患者(HCC 组),35例肝硬化患者(肝硬化组),35例HCC经导管肝动脉化疗栓塞术(TACE)术后患者(TACE术后组)及35例健康志愿者(健康对照组)。检测并比较各组血清B/A比值、AFP、PIVKA-II水平;分析HCC组血清B/A比值、AFP、PIVKA-II之间的相关性;比较不同临床病理特征HCC患者B/A比值、AFP、PIVKA-II;比较HCC组术前、术后血清B/A比值、AFP、PIVKA-II水平;通过受试者工作特征(ROC)曲线分析B/A 比值、AFP、PIVKA-II单独及联合对HCC的诊断价值。结果:HCC组、TACE术后组血清B/A比值、AFP、PIVKA-II水平均显著高于肝硬化组和健康对照组,且HCC组高于TACE术后组(P<0.05)。Pearson相关分析结果显示,HCC组B/A比值与AFP呈正相关(r=0.352,P=0.001),B/A比值与PIVKA-II呈正相关(r=0.327,P=0.003),AFP与PIVKA-II呈正相关(r=0.285,P=0.008)。TNM分期越高、肿瘤直径越大、存在血管侵犯以及分化程度越低的HCC患者B/A比值、AFP、PIVKA-II水平越高(P<0.05)。HCC组术后血清B/A比值、AFP、PIVKA-II水平均显著低于术前(P<0.05)。ROC曲线分析结果显示,B/A 比值、AFP、PIVKA-II单独检测时,曲线下面积(AUC)分别为0.785、0.756、0.802;联合检测的AUC为0.925。联合检测的AUC大于各指标单独检测。结论:B/A比值联合AFP、PIVKA-II检测可显著提高对HCC的诊断效能,为临床诊断提供更有力的依据。
英文摘要:
      Objective: To explore the diagnostic value of total bilirubin to albumin ratio (B/A ratio) combine with alpha-fetoprotein (AFP) and abnormal prothrombin induced by vitamin K absence-II (PIVKA-II) for hepatocellular carcinoma (HCC). Methods: 35 HCC patients (HCC group), 35 cirrhosis patients (cirrhosis group), 35 HCC patients post-transcatheter arterial chemoembolization (TACE) (TACE postoperative group), and 35 healthy volunteers (healthy control group) were selected in our hospital from January 2023 December 2024. The serum B/A ratio, AFP, and PIVKA-II levles were measured and compared across the groups. The correlations between serum B/A ratio, AFP, and PIVKA-II in the HCC group were analyzed. The B/A ratio, AFP, PIVKA-II were compared across different clinical and pathological features in HCC patients. The serum B/A ratio, AFP, and PIVKA-II levels were compared pre and post operation in the HCC group. The diagnostic value of B/A ratio, AFP, PIVKA-II alone and in combination for HCC were analyzed by receiver operating characteristic (ROC) curves. Results: The serum B/A ratio, AFP, and PIVKA-II levels in HCC group and TACE postoperative group were significantly higher than those in the cirrhosis group and healthy control group, and the HCC group was higher than that in the TACE postoperative group (P<0.05). Pearson correlation analysis results showed that, B/A ratio in the HCC group was positively correlated with AFP (r=0.352, P=0.001), B/A ratio was positively correlated with PIVKA-II (r=0.327, P=0.003), and AFP was positively correlated with PIVKA-II (r=0.285, P=0.008). Higher TNM stage, larger tumor diameter, presence of vascular invasion, and lower differentiation degree of HCC patients, who had higher B/A ratio, AFP, and PIVKA-II levels (P<0.05). Serum B/A ratio, AFP, and PIVKA-II levels in the HCC group post operation were significantly lower than those in pre operation (P<0.05). ROC curve analysis results showed that, when B/A ratio, AFP, and PIVKA-II were detected separately, the area under the curve (AUC) was 0.785, 0.756, and 0.802, respectively. The AUC for joint detection was 0.925. The AUC in combination was greater than that of individual detection of each indicator. Conclusion: The combination of B/A ratio, AFP, and PIVKA-II testing significantly improves the diagnostic efficiency for HCC, which provides stronger clinical diagnostic evidence.
View Fulltext   查看/发表评论  下载PDF阅读器
关闭